PRELUDE THERAPEUTICS INC Public Float
PRELUDE THERAPEUTICS INC (PRLD) had Public Float of $14.40 million as of 2025-06-30, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-10
- 2025-06-30: Entity Public Float $14.40M.
- 2024-06-30: Entity Public Float $66.10M.
- 2023-06-30: Entity Public Float $77.10M.
- 2022-06-30: Entity Public Float $65.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $14.40M 10-K · filed 2026-03-10 |
| 2024-06-30 | $66.10M 10-K · filed 2025-03-10 |
| 2023-06-30 | $77.10M 10-K · filed 2024-02-15 |
| 2022-06-30 | $65.30M 10-K · filed 2023-03-15 |
| 2021-06-30 | $343.30M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |